Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression

5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression

US Patent 6969716 · Granted Nov 29, 2005

Estimated economic value: $135,470,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and uses thereof2025
METTL3 inhibitory compounds2025
Inhibitors of receptor interacting protein kinase I for the treatment of disease2025
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof2025
Polyheterocyclic compounds as METTL3 inhibitors2025
EGFR inhibitors2024
Compounds and uses thereof2024
GLS1 inhibitors for treating disease2024
Compositions useful for treating disorders related to KIT2023
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
Therapeutic compounds, compositions and methods of use thereof2023
Polyheterocyclic compounds as METTL3 inhibitors2023